David Lee

机构：University of Iowa, Cedars-Sinai Medical Center, University of Washington, Washington University in St. Louis, PDL BioPharma (United States), Seattle University, The University of Texas Health Science Center at Houston · ORCID：0000-0001-6539-4272

发表论文 141 篇 · 总被引 4982 次 · h-index 29

代表论文

• Engineered receptors for soluble cellular communication and disease sensing (2024 · Nature · 被引 60)
• Method of moments framework for differential expression analysis of single-cell RNA sequencing data (2024 · Cell · 被引 43)
• Design of high-affinity binders to immune modulating receptors for cancer immunotherapy (2025 · Nature Communications · 被引 30)
• Multiplex generation and single-cell analysis of structural variants in mammalian genomes (2025 · Science · 被引 24)
• Combinatorial mapping of E3 ubiquitin ligases to their target substrates (2025 · Molecular Cell · 被引 21)
• Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19 (2024 · Nature Communications · 被引 20)